Multiparametric MRI (mpMRI) improves prostate cancer diagnosis, but conventional apparent diffusion coefficient (ADC) and PI-RADS have poor reliability. We evaluated restriction spectrum imaging MRI (RSI-MRI) as a quantitative, patient-level classifier of higher-grade prostate cancer (grade group ≥2) and compared performance to conventional ADC and PI-RADS. Area under the receiver operating characteristic curve values for ADC, RSI-C1, and PI-RADS were 0.58 [0.51,0.67], 0.76 [0.68,0.83], and 0.78 [0.71,0.85], respectively. RSI-C1 was superior to ADC (p=0.003) as a patient-level classifier of higher-grade prostate cancer. Performance of RSI-C1 was comparable to that of PI-RADS (p=0.59).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords